Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

GLP-1 agonists may increase the risk of hair loss.

An injectable ibuprofen gel speeds up diabetic wound healing by reducing inflammation and promoting tissue growth.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

The DNN-DTIs method accurately predicts drug-target interactions and is useful for drug repositioning.

These medications for BPH have known risks and may have new side effects.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Finasteride helps female-pattern hair loss.

Finasteride reduces movement issues in Parkinson's disease rats.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Apremilast improved symptoms in patients with severe skin conditions.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.